Atorvastatin 10 mg Tablets (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Han In Pharmaceutical Co., Ltd.
MFDS item code 201701343 · Approved 2017.03.20 · Insurance code 657203250
Improvement of hyperlipidemia and prevention of cardiovascular diseases (such as myocardial infarction and stroke)
This medication is used to reduce the risk of cardiovascular diseases. In particular, it lowers the risk of myocardial infarction and stroke in adults with multiple risk factors for coronary heart disease and those with type 2 diabetes, and it is also effective in vascular interventions and chronic stable angina. Furthermore, it lowers the risk of non-fatal myocardial infarction, stroke, hospitalizations for congestive heart failure, and angina in patients with clinical evidence. This drug helps improve cholesterol and triglyceride levels in patients with primary hypercholesterolemia and mixed dyslipidemia, and increases HDL cholesterol. It is also used in patients with dysbetalipoproteinemia, elevated triglycerides, and familial hypercholesterolemia who do not respond to other therapies. Among pediatric patients, it is effective in controlling cholesterol levels in patients with heterozygous familial hypercholesterolemia who meet specific criteria. Therefore, this medication is used to improve patients' health by reducing the risk of cardiovascular diseases and improving dyslipidemia.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. The medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (the 40 mg dose is for patients requiring an LDL cholesterol reduction of 45 % or more). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into consideration treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor the response to treatment. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It should be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Older adults: Efficacy and safety in patients aged 70 years or older are similar to those in the general adult patient population.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses higher than 20 mg of this medicine in pediatric patients).
This medication should be discontinued immediately if there are unusual symptoms in the muscles or if muscle enzyme levels rise significantly. Special caution is required, especially when serious myopathy or rhabdomyolysis is suspected, as there is a risk of kidney function deterioration. This drug should not be used in patients with certain diseases or allergic reactions, pregnant or nursing women, children under 10 years of age, and those taking some other medications. It should be used cautiously in cases of liver or kidney problems, alcohol addiction, hypothyroidism, and a history of muscle diseases. Elderly patients also require caution due to a higher risk of muscle-related side effects. During treatment, if symptoms such as fatigue, muscle pain, muscle weakness, or fever occur, you must inform healthcare professionals immediately, and regular blood tests to check liver function and muscle enzyme levels are important. This medication can interact with various drugs, so if you are taking other medications, you must inform your doctor or pharmacist, especially if used in conjunction with certain antibiotics, antifungals, antivirals, blood pressure medications, hypoglycemic agents, oral contraceptives, etc. Women who are pregnant or of childbearing potential must use adequate contraception, and if pregnancy is confirmed, they should stop taking it immediately. Nursing mothers should not take this medication. There is no specific antidote in case of overdose, so treatment should be symptomatic based on symptoms while closely monitoring liver function and muscle enzyme levels. Keep this medication out of the reach of children, and store it in its original container to prevent misuse or deterioration of quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container as it may be sensitive to light and air. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius. Proper storage will safely preserve the effectiveness of the medication.
White circular film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Han In Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.